Physician profile
Jay P Glover
NPI 1184917957
$1,813.84
in general payments reported to CMS, 2019-2025
9 companies · $333 in 2025
The $333 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $415 · 2020: $187 · 2021: $268 · 2022: $16.05 · 2023: $99.53 · 2024: $497 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $928.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $706.25 | 2019-2024 | Constellation, Ngenuity |
| Regeneron Healthcare Solutions, INC. | $487.85 | 2019-2025 | Eylea Hd, Eylea |
| Novartis Pharmaceuticals Corporation | $217.16 | 2019 | |
| Genentech USA, INC. | $162.73 | 2022-2025 | Vabysmo, Susvimo |
| Abbvie INC. | $80.67 | 2023-2025 | |
| Ani Pharmaceuticals, INC. | $63.82 | 2025 | Yutiq, Purified Cortrophin Gel |
| Apellis Pharmaceuticals, INC. | $48.38 | 2023-2025 | Syfovre |
| Astellas Pharma US INC | $31.15 | 2025 | Izervay |
| Amgen INC. | $15.83 | 2025 | Pavblu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Glover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.